EVALUATION OF THE EFFECT OF ITRACONAZOLE, A POTENT CYP3A4 INHIBITOR, ON THE PHARMACOKINETICS OF A SINGLE ORAL DOSE OF TAK-906, A PERIPHERALLY-SELECTIVE D<sub>2</sub>/D<sub>3</sub> DOPAMINE RECEPTOR ANTAGONIST

Chunlin Chen  1     Wenwen Zhang  1     Muhammad Bari  2     Mike Baratta  1     Maria Rosario  1    
1 Takeda Development Center Americas Inc.,Cambridge,United States
2 Takeda International - UK Branch,London,United Kingdom

Conference
UEG Week 2018

Citation
United European Gastroenterology Journal 2018; 6 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing